Life Science Compassionate Access Summit

Life Science Compassionate Access Summit in Philadelphia on Monday, March 18, 2019
Life Science Compassionate Access Summit in Philadelphia on Monday, March 18, 2019
Monday, March 18, 2019 -- Tuesday, March 19, 2019, 0900 - 1700
Explore industry trends for the use of real-world data, and discuss different outlooks and ethical approaches on compassionate use requests to advance public health in the pharmaceutical industry.

In today’s transparent clinical trial environment, HCP receive constant communication about trials and can offer an alternative treatment under expanded access, also known as compassionate use. Compassionate Access is a special exception made for the use of investigational drugs, biologics or medical devices used on patients during extenuating circumstances on an individual basis. As a life science organization and medical expert, it is your obligation to review fast and fairly to approve this request to send to regulators in the nation for regulators to ship the drug to the physicians. These responsibilities will ensure patient safety and expanded access capabilities, to execute a proper program that is compliant.

At ExL’s Life Science Compassionate Access Summit, attendees will be able to join industry leaders to explore compassionate use departments, compliance, market access, and understand the ethics of regulatory affairs to advance public health and widen the application within the life science industry.

Top Five Reasons to Attend
1. Examine best practices to implement, integrate, and enhance fair patient enrollment criteria and practices for an Expanded Access Program
2. Implement EAPs to support patient access from a stakeholders standpoint
3. Review industry trends and the use of Real-World Data in an Expanded Access Program
4. Discuss the benefits and challenges of the new legislative “Right to Try” bill
5. Explore how to enhance all factors and address regulatory, ethical, and management aspects of an EAP program

On Monday March 18, 2019 at 9:00 am (ends Tuesday March 19, 2019 at 5:00 pm)

Category: Conferences - Science, Health & Medicine - Pharmaceuticals - Regulatory Affairs


Early Bird Pricing — Register by February 1, 2019: USD 1895.0
Standard Pricing: USD 2095.0
Onsite Pricing: USD 2195.0

Venue: Sonesta Philadelphia Downtown Rittenhouse Square, 1800 Market Street, Philadelphia, 19103


Starting Price Per Person
$ 1895.00 USD
Other Information
Sonesta Philadelphia Downtown Rittenhouse Square
1800 Market Street
Philadelphia 19103
United States
( Convention - Exhibition Center )

Event Organizer Contact
Emily Schriver
More Events
Event ID: 142725

Get Events in Your Inbox

We have over 100,000 Events in 80+ Categories. Tell us what type of events you like, and we will send them to your inbox